Monday, May 27, 2013 12:18:01 AM
MarketwiredPress Release: ImmuCell Corporation – Tue, May 14, PORTLAND, ME--(Marketwired - May 14, 2013) - ImmuCell Corporation (NASDAQ: ICCC) today announced the results of its operations for the three-month period ended March 31, 2013.
During the three-month period ended March 31, 2013, product sales increased by 8%, or $130,000, to $1,847,000 in comparison to $1,717,000 during the same period in 2012.
Net operating income was $327,000 during the three-month period ended March 31, 2013, in comparison to net operating income of $281,000 during the same period in 2012. The net income was $204,000, or $0.07 per share, during the three-month period ended March 31, 2013, in comparison to net income of $155,000, or $0.05 per share, during the same period in 2012. The improved financial performance is largely due to increased gross margin from sales of First Defense®.
"In this extremely challenging dairy and beef economy with a record low milk-to-feed price ratio narrowing our customers' profit margins, our product sales increased by 8% and 5% during the three-month and twelve-month periods ended March 31, 2013, respectively," commented Michael F. Brigham, President and CEO. "This sales growth contributed to our continued profitability, while we are actively seeking a partner to help us complete the development and commercialization of Mast Out®."
Cash, cash equivalents and short-term investments increased by 8%, or $392,000, to $5,305,000 as of March 31, 2013, in comparison to $4,914,000 as of December 31, 2012. Stockholders' equity increased by 2%, or $219,000, to $9,413,000 as of March 31, 2013, in comparison to $9,195,000 as of December 31, 2012. The Company had 3,019,000 shares of common stock outstanding as of March 31, 2013.
About ImmuCell:
ImmuCell Corporation's (NASDAQ: ICCC) purpose is to create scientifically-proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. Press releases and other information about the Company are available at our web-site, (http://www.immucell.com).
Contact:
Michael F. Brigham, President and Chief Executive Officer
(207) 878-2770 Ext. 3106
(Unaudited)
For the Three-Month Periods Ended March 31,
(In thousands, except per share amounts) 2013 2012
Product sales $ 1,847 $ 1,717
Costs of goods sold 793 704
Gross margin 1,054 1,013
Product development expenses 267 248
Sales, marketing and administrative expenses 461 484
Other operating expenses 728 732
NET OPERATING INCOME 326 281
Other revenues (expenses), net 44 (10 )
INCOME BEFORE INCOME TAXES 370 271
Income tax expense 166 116
NET INCOME $ 204 $ 155
Weighted average common shares outstanding:
Basic 3,019 3,016
Diluted 3,084 3,103
NET INCOME PER SHARE:
Basic $ 0.07 $ 0.05
Diluted $ 0.07 $ 0.05
(Unaudited)
As of
March 31, 2013 As of
December 31, 2012
(In thousands)
Cash, cash equivalents and short-term investments $ 5,305 $ 4,914
Total assets 11,111 11,030
Net working capital 7,082 6,697
Stockholders' equity $ 9,413 $ 9,195
.
.
Contact:.
.
Michael F. Brigham
President and Chief Executive Officer
(207) 878-2770 Ext. 3106
Recent ICCC News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/17/2024 05:49:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 04:25:45 PM
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 08/27/2024 08:32:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 07:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 05:05:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 05:04:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:05:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:05:29 PM
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 • GlobeNewswire Inc. • 08/13/2024 08:05:00 PM
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 • GlobeNewswire Inc. • 08/07/2024 08:05:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:05:09 PM
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 • GlobeNewswire Inc. • 07/09/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 05:38:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 03:33:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 11:49:43 AM
- ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain® • GlobeNewswire Inc. • 06/05/2024 08:05:00 PM
- ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders • GlobeNewswire Inc. • 06/04/2024 08:05:00 PM
- Form SCHEDULE 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/22/2024 08:50:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:05:51 PM
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024 • GlobeNewswire Inc. • 05/08/2024 05:00:48 PM
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 • GlobeNewswire Inc. • 04/09/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 06:55:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:32 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM